Loading…

Myricetin attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models

Acute lung injury is a common clinical syndrome associated with significant morbidity. Myricetin has been demonstrated to inhibit inflammation in a variety of diseases. In this study, we aimed to investigate the protective effects of myricetin on inflammation in lipopolysaccharide-stimulated RAW 264...

Full description

Saved in:
Bibliographic Details
Published in:Future medicinal chemistry 2018-10, Vol.10 (19), p.2253-2264
Main Authors: Hou, Wei, Hu, Siyi, Su, Zhenzhong, Wang, Qi, Meng, Guangping, Guo, Tingting, Zhang, Jie, Gao, Peng
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c448t-c8f669522e692d0d9d7f3bbbf3dd04293a1ccbe01876241d8058f14d710036ef3
cites cdi_FETCH-LOGICAL-c448t-c8f669522e692d0d9d7f3bbbf3dd04293a1ccbe01876241d8058f14d710036ef3
container_end_page 2264
container_issue 19
container_start_page 2253
container_title Future medicinal chemistry
container_volume 10
creator Hou, Wei
Hu, Siyi
Su, Zhenzhong
Wang, Qi
Meng, Guangping
Guo, Tingting
Zhang, Jie
Gao, Peng
description Acute lung injury is a common clinical syndrome associated with significant morbidity. Myricetin has been demonstrated to inhibit inflammation in a variety of diseases. In this study, we aimed to investigate the protective effects of myricetin on inflammation in lipopolysaccharide-stimulated RAW 264.7 cells and lipopolysaccharide-induced lung injury model. In this study, we detected the anti-inflammatory effects of myricetin by ELISA, RT-PCR and Western blot, respectively. Myricetin significantly inhibited the production of the proinflammatory cytokines and . It exerted an anti-inflammatory effect through suppressing the NF-κB p65 and AKT activation in NF-κB pathway and JNK, p-ERK and p38 in MAPK signaling pathway. Myricetin alleviated acute lung injury by inhibiting macrophage activation, and inhibited inflammation and . It may be a potential therapeutic candidate for the prevention of inflammatory diseases.
doi_str_mv 10.4155/fmc-2018-0172
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2087588309</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2087588309</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-c8f669522e692d0d9d7f3bbbf3dd04293a1ccbe01876241d8058f14d710036ef3</originalsourceid><addsrcrecordid>eNp1kLtPwzAQxi0EolXpyIoysqTYzsseq4qXVATioY6WY5_BKHFK7Az973GV0o0bfD7pd5---xC6JHiRk6K4Ma1KKSYsxaSiJ2hKqqJMGafV6fFP-ATNvf_GsTLKeFmco0mGMS8oy6Zo87TrrYJgXSJDADfIAD5Zv7yl1ulBgU6sM41sWxls5-KQvC43CS3zRZW0UvXd9kt-xg3pdNJ2g4f4amj8BTozsvEwP_QZ-ri7fV89pOvn-8fVcp2qPGchVcyUZbRCoeRUY811ZbK6rk2mNc4pzyRRqoZ4YlXSnGiGC2ZIrisSrynBZDN0Pepu--5nAB9Ea72CppEOoh1BMasKxjLMI5qOaHTtfQ9GbHvbyn4nCBb7OEWMU-zjFPs4I391kB7qFvSR_gsvAnwEzBCGHryy4BSIcYobVlkH_4j_ArYGgqY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2087588309</pqid></control><display><type>article</type><title>Myricetin attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models</title><source>PubMed Central Free</source><creator>Hou, Wei ; Hu, Siyi ; Su, Zhenzhong ; Wang, Qi ; Meng, Guangping ; Guo, Tingting ; Zhang, Jie ; Gao, Peng</creator><creatorcontrib>Hou, Wei ; Hu, Siyi ; Su, Zhenzhong ; Wang, Qi ; Meng, Guangping ; Guo, Tingting ; Zhang, Jie ; Gao, Peng</creatorcontrib><description>Acute lung injury is a common clinical syndrome associated with significant morbidity. Myricetin has been demonstrated to inhibit inflammation in a variety of diseases. In this study, we aimed to investigate the protective effects of myricetin on inflammation in lipopolysaccharide-stimulated RAW 264.7 cells and lipopolysaccharide-induced lung injury model. In this study, we detected the anti-inflammatory effects of myricetin by ELISA, RT-PCR and Western blot, respectively. Myricetin significantly inhibited the production of the proinflammatory cytokines and . It exerted an anti-inflammatory effect through suppressing the NF-κB p65 and AKT activation in NF-κB pathway and JNK, p-ERK and p38 in MAPK signaling pathway. Myricetin alleviated acute lung injury by inhibiting macrophage activation, and inhibited inflammation and . It may be a potential therapeutic candidate for the prevention of inflammatory diseases.</description><identifier>ISSN: 1756-8919</identifier><identifier>EISSN: 1756-8927</identifier><identifier>DOI: 10.4155/fmc-2018-0172</identifier><identifier>PMID: 30095283</identifier><language>eng</language><publisher>England: Future Science Ltd</publisher><subject>acute lung injury ; inflammatory diseases ; lipopolysaccharide ; macrophage ; myricetin</subject><ispartof>Future medicinal chemistry, 2018-10, Vol.10 (19), p.2253-2264</ispartof><rights>2018 Newlands Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-c8f669522e692d0d9d7f3bbbf3dd04293a1ccbe01876241d8058f14d710036ef3</citedby><cites>FETCH-LOGICAL-c448t-c8f669522e692d0d9d7f3bbbf3dd04293a1ccbe01876241d8058f14d710036ef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30095283$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hou, Wei</creatorcontrib><creatorcontrib>Hu, Siyi</creatorcontrib><creatorcontrib>Su, Zhenzhong</creatorcontrib><creatorcontrib>Wang, Qi</creatorcontrib><creatorcontrib>Meng, Guangping</creatorcontrib><creatorcontrib>Guo, Tingting</creatorcontrib><creatorcontrib>Zhang, Jie</creatorcontrib><creatorcontrib>Gao, Peng</creatorcontrib><title>Myricetin attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models</title><title>Future medicinal chemistry</title><addtitle>Future Med Chem</addtitle><description>Acute lung injury is a common clinical syndrome associated with significant morbidity. Myricetin has been demonstrated to inhibit inflammation in a variety of diseases. In this study, we aimed to investigate the protective effects of myricetin on inflammation in lipopolysaccharide-stimulated RAW 264.7 cells and lipopolysaccharide-induced lung injury model. In this study, we detected the anti-inflammatory effects of myricetin by ELISA, RT-PCR and Western blot, respectively. Myricetin significantly inhibited the production of the proinflammatory cytokines and . It exerted an anti-inflammatory effect through suppressing the NF-κB p65 and AKT activation in NF-κB pathway and JNK, p-ERK and p38 in MAPK signaling pathway. Myricetin alleviated acute lung injury by inhibiting macrophage activation, and inhibited inflammation and . It may be a potential therapeutic candidate for the prevention of inflammatory diseases.</description><subject>acute lung injury</subject><subject>inflammatory diseases</subject><subject>lipopolysaccharide</subject><subject>macrophage</subject><subject>myricetin</subject><issn>1756-8919</issn><issn>1756-8927</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kLtPwzAQxi0EolXpyIoysqTYzsseq4qXVATioY6WY5_BKHFK7Az973GV0o0bfD7pd5---xC6JHiRk6K4Ma1KKSYsxaSiJ2hKqqJMGafV6fFP-ATNvf_GsTLKeFmco0mGMS8oy6Zo87TrrYJgXSJDADfIAD5Zv7yl1ulBgU6sM41sWxls5-KQvC43CS3zRZW0UvXd9kt-xg3pdNJ2g4f4amj8BTozsvEwP_QZ-ri7fV89pOvn-8fVcp2qPGchVcyUZbRCoeRUY811ZbK6rk2mNc4pzyRRqoZ4YlXSnGiGC2ZIrisSrynBZDN0Pepu--5nAB9Ea72CppEOoh1BMasKxjLMI5qOaHTtfQ9GbHvbyn4nCBb7OEWMU-zjFPs4I391kB7qFvSR_gsvAnwEzBCGHryy4BSIcYobVlkH_4j_ArYGgqY</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Hou, Wei</creator><creator>Hu, Siyi</creator><creator>Su, Zhenzhong</creator><creator>Wang, Qi</creator><creator>Meng, Guangping</creator><creator>Guo, Tingting</creator><creator>Zhang, Jie</creator><creator>Gao, Peng</creator><general>Future Science Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20181001</creationdate><title>Myricetin attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models</title><author>Hou, Wei ; Hu, Siyi ; Su, Zhenzhong ; Wang, Qi ; Meng, Guangping ; Guo, Tingting ; Zhang, Jie ; Gao, Peng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-c8f669522e692d0d9d7f3bbbf3dd04293a1ccbe01876241d8058f14d710036ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>acute lung injury</topic><topic>inflammatory diseases</topic><topic>lipopolysaccharide</topic><topic>macrophage</topic><topic>myricetin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hou, Wei</creatorcontrib><creatorcontrib>Hu, Siyi</creatorcontrib><creatorcontrib>Su, Zhenzhong</creatorcontrib><creatorcontrib>Wang, Qi</creatorcontrib><creatorcontrib>Meng, Guangping</creatorcontrib><creatorcontrib>Guo, Tingting</creatorcontrib><creatorcontrib>Zhang, Jie</creatorcontrib><creatorcontrib>Gao, Peng</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Future medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hou, Wei</au><au>Hu, Siyi</au><au>Su, Zhenzhong</au><au>Wang, Qi</au><au>Meng, Guangping</au><au>Guo, Tingting</au><au>Zhang, Jie</au><au>Gao, Peng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myricetin attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models</atitle><jtitle>Future medicinal chemistry</jtitle><addtitle>Future Med Chem</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>10</volume><issue>19</issue><spage>2253</spage><epage>2264</epage><pages>2253-2264</pages><issn>1756-8919</issn><eissn>1756-8927</eissn><abstract>Acute lung injury is a common clinical syndrome associated with significant morbidity. Myricetin has been demonstrated to inhibit inflammation in a variety of diseases. In this study, we aimed to investigate the protective effects of myricetin on inflammation in lipopolysaccharide-stimulated RAW 264.7 cells and lipopolysaccharide-induced lung injury model. In this study, we detected the anti-inflammatory effects of myricetin by ELISA, RT-PCR and Western blot, respectively. Myricetin significantly inhibited the production of the proinflammatory cytokines and . It exerted an anti-inflammatory effect through suppressing the NF-κB p65 and AKT activation in NF-κB pathway and JNK, p-ERK and p38 in MAPK signaling pathway. Myricetin alleviated acute lung injury by inhibiting macrophage activation, and inhibited inflammation and . It may be a potential therapeutic candidate for the prevention of inflammatory diseases.</abstract><cop>England</cop><pub>Future Science Ltd</pub><pmid>30095283</pmid><doi>10.4155/fmc-2018-0172</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1756-8919
ispartof Future medicinal chemistry, 2018-10, Vol.10 (19), p.2253-2264
issn 1756-8919
1756-8927
language eng
recordid cdi_proquest_miscellaneous_2087588309
source PubMed Central Free
subjects acute lung injury
inflammatory diseases
lipopolysaccharide
macrophage
myricetin
title Myricetin attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A44%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myricetin%20attenuates%20LPS-induced%20inflammation%20in%20RAW%20264.7%20macrophages%20and%20mouse%20models&rft.jtitle=Future%20medicinal%20chemistry&rft.au=Hou,%20Wei&rft.date=2018-10-01&rft.volume=10&rft.issue=19&rft.spage=2253&rft.epage=2264&rft.pages=2253-2264&rft.issn=1756-8919&rft.eissn=1756-8927&rft_id=info:doi/10.4155/fmc-2018-0172&rft_dat=%3Cproquest_cross%3E2087588309%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c448t-c8f669522e692d0d9d7f3bbbf3dd04293a1ccbe01876241d8058f14d710036ef3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2087588309&rft_id=info:pmid/30095283&rfr_iscdi=true